Merck
CN

UHPLC Analysis of Temsirolimus and Sirolimus on Titan C18

UHPLC Analysis of Temsirolimus and Sirolimus on Titan™ C18 application for UHPLC

材料

标准

产品编号
说明
价格

Temsirolimus

≥98% (HPLC)

西罗莫司 溶液

1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

CONDITIONS

column

Titan C18 10 cm x 2.1 mm, 1.9 μm particles (577124-U)

mobile phase

[A] 0.1% formic acid in water, [B] methanol

gradient

75% B for 2 minutes, 75% B to 90% B from 2 to 12 minutes, 90% B from 12 to 14 minutes.

flow rate

0.3 mL/min

pressure

3300 psi (228 bar)

column temp.

55 °C

detector

UV, 276 nm

injection

2.0 μL

sample

100 μg/mL each in 20% methanol

说明

分析说明

The anticancer agents temsirolimus and sirolimus are shown here resolved, efficienttly and rapidly, on a Titan C18 UHPLC column. The highest grade LC-MS solvents were used to supply low background interference and low particulate contaminants for robust, trouble-free operation. Cerilliant CRMs provided reliable identification and quantification.

法律信息

Titan is a trademark of Sigma-Aldrich Co. LLC